Immunological Adverse Events After Autologous Hematopoietic Stem Cell Transplantation in Systemic Sclerosis Patients
Patrick‐Pascal Strunz(Universitätsklinikum Würzburg), Marc Schmalzing(University of Würzburg), Matthias Froehlich(Universitätsklinikum Würzburg), Ann‐Christin Pecher(Center for Rheumatology), Michael Gernert(Universitätsklinikum Würzburg), Eva C. Schwaneck(University of Würzburg), Anna Fleischer(Universitätsklinikum Würzburg), Hans‐Peter Tony(University of Würzburg), Jörg Henes(University of Tübingen)
Cited by 14
Related Papers
CD19-Targeting CAR T Cells for Myositis and Interstitial Lung Disease Associated With Antisynthetase Syndrome
|JAMA|2023|234
Increased Risk for Malignancies in 131 Affected CTLA4 Mutation Carriers
|Frontiers in Immunology|2018|103
Intestinal B cells license metabolic T-cell activation in NASH microbiota/antigen-independently and contribute to fibrosis by IgA-FcR signalling
|Journal of Hepatology|2023|92
Prevalence of autoimmune disease in women with premature ovarian failure
|The European Journal of Contraception & Reproductive Health Care|2019|77